Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Motorcyclist Killed in Crash at Monterey Road and Valleyhaven Way


Jeep, Motorcycle Collide in Fatal San Jose Accident

San Jose, CA (March 3, 2020) – A motorcyclist was killed in a crash in San Jose. The fatal accident occurred on the evening of March 3 at Monterey Road and Valleyhaven Way.

A man was riding a Suzuki motorcycle on Monterey Road. He was approaching Valleyhaven Way when a Jeep made a left turn in front of him. The motorcyclist died at the accident scene. The female driver of the Jeep and a child passenger were hospitalized with minor injuries.

Our heartfelt condolences go out to the friends and loved ones of the victim

#San Jose

#95111


May 7, 2020

CHP Officer Injured in Crash at 6th and H Streets

3 Vehicles Collide in Modesto Accident...


May 22, 2020

3 Injured in Crash at 24th Street and 34th Avenue

2 Police Officers Involved in Sacramento Accident...


December 26, 2019

Crash on La Purisima Road Causes Major Injuries

2 Vehicles Involved in Lompoc Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.